SI1881826T1 - Uporaba benzoil derivata 3-aminokarbazola za zdravljenje motnje, povezane s produkcijo prostaglandina E2 (PGE2) - Google Patents

Uporaba benzoil derivata 3-aminokarbazola za zdravljenje motnje, povezane s produkcijo prostaglandina E2 (PGE2)

Info

Publication number
SI1881826T1
SI1881826T1 SI200630781T SI200630781T SI1881826T1 SI 1881826 T1 SI1881826 T1 SI 1881826T1 SI 200630781 T SI200630781 T SI 200630781T SI 200630781 T SI200630781 T SI 200630781T SI 1881826 T1 SI1881826 T1 SI 1881826T1
Authority
SI
Slovenia
Prior art keywords
aminocarbazole
pge2
prostaglandin
treatment
production
Prior art date
Application number
SI200630781T
Other languages
English (en)
Slovenian (sl)
Inventor
Lorenzo Polenzani
Giorgina Mangano
Isabella Coletta
Maria Alessandra Alisi
Nicola Cazzolla
Guido Furlotti
Caterina Maugeri
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of SI1881826T1 publication Critical patent/SI1881826T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Psychology (AREA)
  • Dermatology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
SI200630781T 2005-05-19 2006-05-03 Uporaba benzoil derivata 3-aminokarbazola za zdravljenje motnje, povezane s produkcijo prostaglandina E2 (PGE2) SI1881826T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT000909A ITMI20050909A1 (it) 2005-05-19 2005-05-19 Uso di un benzoil derivato dal 3-ammino-carbazolo per la produzione di un farmaco per il trattamento di un disturbo associato alla produzione di prostaglandina e2-pge2-
PCT/EP2006/004348 WO2006122680A1 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
EP06753538A EP1881826B1 (en) 2005-05-19 2006-05-03 Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)

Publications (1)

Publication Number Publication Date
SI1881826T1 true SI1881826T1 (sl) 2010-10-29

Family

ID=35219704

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200630781T SI1881826T1 (sl) 2005-05-19 2006-05-03 Uporaba benzoil derivata 3-aminokarbazola za zdravljenje motnje, povezane s produkcijo prostaglandina E2 (PGE2)

Country Status (23)

Country Link
US (1) US8686021B2 (enExample)
EP (1) EP1881826B1 (enExample)
JP (1) JP5086991B2 (enExample)
KR (1) KR101312579B1 (enExample)
CN (1) CN101166528B (enExample)
AR (1) AR054126A1 (enExample)
AT (1) ATE473739T1 (enExample)
AU (1) AU2006246688B2 (enExample)
BR (1) BRPI0609718A2 (enExample)
CA (1) CA2604562C (enExample)
DE (1) DE602006015457D1 (enExample)
DK (1) DK1881826T3 (enExample)
EA (1) EA012724B1 (enExample)
ES (1) ES2347174T3 (enExample)
GE (1) GEP20094738B (enExample)
IL (1) IL186072A (enExample)
IT (1) ITMI20050909A1 (enExample)
MX (1) MX2007013491A (enExample)
PL (1) PL1881826T3 (enExample)
PT (1) PT1881826E (enExample)
SI (1) SI1881826T1 (enExample)
UA (1) UA94044C2 (enExample)
WO (1) WO2006122680A1 (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20051523A1 (it) 2005-08-03 2007-02-04 Acraf Composto del 3-ammino-carbazolo composizione farmaceutica che lo contiene e metodo per prepararlo
EP2119705A1 (en) 2008-05-14 2009-11-18 AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO A.C.R.A.F. S.p.A. 3-Aminocarbozole compound, pharmaceutical composition containing it and preparation method therefor
US8880004B2 (en) 2009-05-14 2014-11-04 Qualcomm Incorporated System and method for resolving conflicts between air interfaces in a wireless communication system

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002241368A (ja) * 1997-02-18 2002-08-28 Shionogi & Co Ltd 新規ベンゾラクタム誘導体およびそれを含有する医薬組成物
US6399631B1 (en) 1999-07-23 2002-06-04 Pfizer Inc. Carbazole neuropeptide Y5 antagonists
AU6000900A (en) 1999-07-23 2001-02-13 Astrazeneca Uk Limited Carbazole derivatives and their use as neuropeptide y5 receptor ligands
JP2003507424A (ja) * 1999-08-26 2003-02-25 ブリストル−マイヤーズ スクイブ カンパニー Ｎｐｙアンタゴニスト：スピロイソキノリノン誘導体
DE10125961A1 (de) 2001-05-29 2002-12-12 Boehringer Ingelheim Int Carbazolderivate und deren Verwendung zur Herstellung einer Arzneimittelzusammensetzung zur Behandlung von im Zusammenhang mit NPY stehenden Leiden
CA2403307A1 (en) * 2001-10-23 2003-04-23 Neurogen Corporation Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
KR20030042344A (ko) * 2001-11-22 2003-05-28 한국생명공학연구원 에레모필란계 화합물 또는 곰취추출물을 유효성분으로함유하는 염증질환 치료제, 면역질환 치료제, 및 암 치료제
ES2193875B2 (es) * 2002-04-09 2005-03-01 Laboratorios Del Dr. Esteve, S.A. Derivados de benzoxazinona, su preparacion y su aplicacion como medicamentos.
KR100402714B1 (ko) * 2002-12-23 2003-11-13 한국생명공학연구원 디테르펜계 화합물을 염증질환, 면역질환 및 암 치료제로사용하는 신규한 용도

Also Published As

Publication number Publication date
CN101166528A (zh) 2008-04-23
EP1881826A1 (en) 2008-01-30
IL186072A0 (en) 2008-08-07
CA2604562C (en) 2013-09-17
ITMI20050909A1 (it) 2006-11-20
IL186072A (en) 2012-05-31
ES2347174T3 (es) 2010-10-26
PT1881826E (pt) 2010-08-05
CN101166528B (zh) 2011-06-15
AU2006246688A1 (en) 2006-11-23
UA94044C2 (ru) 2011-04-11
JP2008540591A (ja) 2008-11-20
JP5086991B2 (ja) 2012-11-28
KR101312579B1 (ko) 2013-09-30
KR20080018898A (ko) 2008-02-28
WO2006122680A1 (en) 2006-11-23
GEP20094738B (en) 2009-07-27
MX2007013491A (es) 2008-01-24
PL1881826T3 (pl) 2010-12-31
CA2604562A1 (en) 2006-11-23
AR054126A1 (es) 2007-06-06
US20080287518A1 (en) 2008-11-20
BRPI0609718A2 (pt) 2011-10-18
EP1881826B1 (en) 2010-07-14
EA012724B1 (ru) 2009-12-30
DE602006015457D1 (de) 2010-08-26
HK1119571A1 (en) 2009-03-13
ATE473739T1 (de) 2010-07-15
EA200702534A1 (ru) 2008-04-28
AU2006246688B2 (en) 2011-09-22
US8686021B2 (en) 2014-04-01
DK1881826T3 (da) 2010-11-01

Similar Documents

Publication Publication Date Title
GB0615620D0 (en) A process for the preparation of optically active intermediates
PT2358669E (pt) Alfa-ceto-perácidos e métodos para produzir e usar os mesmos
PL1993673T3 (pl) Wstrzykiwana skojarzona terapia dla zaburzeń oczu
HRP20141209T1 (hr) Modulatori receptora prostaciklina (pgi2) korisni za lijeäśenje poremeä†aja povezanih s time
PL2370413T3 (pl) Modulatory receptora prostacykliny (PGI2) użyteczne w leczeniu zaburzeń z nimi związanych
EP2175794A4 (en) Device for the modulation of cardiac end diastolic volume
IL194076A0 (en) Imidazolothiazole compounds for the treatment of disease
PL2247602T3 (pl) Pochodne O-glukuronido-adamantylowe jako inhibitory dipeptydylopeptydazy IV do leczenia cukrzycy
DK1878584T3 (da) Fremgangsmåde til fremstilling af et flerlagslegeme med mikrooptik
SI1704141T1 (sl) Nitrooksi-derivati prostaglandinov
HU0500170D0 (en) New compounds with therapeutic effects
ZA200704918B (en) Methods for the production of ansamitocins
GB0822639D0 (en) By virtue of section 39(1)(a) of the Patents Act 1977
PT2343292E (pt) Novo derivado de prostaglandina i2
EP2132138A4 (en) PROCESS FOR THE PRODUCTION OF CYANIDES
IL188856A0 (en) Novel piperidine derivatives as chemokine receptor modulators useful for the treatment of respiratory diseases
ZA200904722B (en) Prostacyclin derivatives
EP2211985A4 (en) A device for the treatment of aneurysm
IL186072A0 (en) Use of a benzoyl derivative of 3-aminocarbazole for the treatment of a disorder associated with the production of prostaglandin e2 (pge2)
IL181332A0 (en) Prostaglandin derivatives for treating gastrointestinal disorder
PT2160438T (pt) Métodos de produção de pentóxido de fósforo
PL2257619T3 (pl) Zastosowanie substytutu węglowego do wytwarzania drożdży
IL184316A0 (en) Use of a trpc channel for the treatment of a cardiovascular disease
PL1700855T3 (pl) Sposób wytwarzania tazarotenu
SI1844019T1 (sl) Postopek za pripravo losartana